The percentage of PD-L1-positive cells in Melan-A-positive tumor cells was significantly decreased in the GANT61-treated group as indicated by the LI (34 ± 2.23%) compared to the control group’s LI (72 ± 2.42%) (Figure 3F, p < 0.05). Here, MLANA is linked to neoplasm.